A number of studies support NAD + regeneration as a therapeutic strategy to benefit patients with obesity.[27] For examples, natural NAD + precursor activators such as nicotinamide riboside (NR) administered via dietary supplements to high-fat fed mice protected against diet-induced obesity, increased energy metabolism, and improved insulin sensitivity;[41] some of these effects were shown to be mediated by NAD + -dependent SIRT1 activation.[42] Similarly, systemic administration of NMN improved glucose tolerance and diet- and age-related insulin resistant conditions.[43, 44] However, dietary supplemental NAD + precursors (e.g., NR, NMN) require chronic administration and/or very high pharmacological doses to achieve physiologically beneficial enhancements in the NAD + levels, which potentially limit use in humans.[27] It could be predicted that combined administration of sub-maximal doses of dietary supplements and NNMT inhibitors that function as activators of NAD + might produce synergistic improvements in diet-induced obesity, and reduce adverse effects associated with chronic high-dose administration of dietary supplemental NAD + precursors
designed and synthesized multifunctional selenium nanoparticles (SeNPs) with baicalin and folic acid (FA) surface modifications for targeted therapy of HBV-infected HCC
Glia-neuron energy metabolism in health and diseases: new insights into the role of nervous system metabolic transporters
These frameworks mean that standardized nanoformulations of apigenin or ellagic acid would need substantially more data than conventional plant extracts to meet regulatory approval
By modulating MMPs and TIMPs, the SCPs prevent plaque neovascularization and hemorrhage, in addition to stabilizing plaques [27]
